Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.39 |
| ▸ | CFTR | P13569 | 1/20 | 0.39 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.36 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.35 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.35 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.35 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.35 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.35 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.35 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.34 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27933440 | 0.85 | PTGS2 (0.43) | ALDH1A1PDE4BCFTRGOPCKMT2A | |
| SCHEMBL9281448 | 0.80 | PTGS2 (0.47) | ALDH1A1PDE4BCFTRGOPCLMNA | |
| SCHEMBL27933484 | 0.79 | CFTR (0.41) | ALDH1A1PDE4BCFTRGOPCKMT2A | |
| SCHEMBL27933609 | 0.77 | CFTR (0.36) | ALDH1A1CFTRGOPCKMT2AL3MBTL1 | |
| SCHEMBL11546612 | 0.77 | MAOA (0.40) | ALDH1A1TSHRKMT2APTGS2 | |
| Hydrochloric Acid SCHEMBL27546053 | 0.75 | CFTR (0.34) | ALDH1A1PDE4BCFTRGOPCLMNA | |
| SCHEMBL27949026 | 0.74 | PTGS2 (0.42) | ALDH1A1PDE4BCFTRGOPCKMT2A | |
| SCHEMBL26880221 | 0.72 | ALDH1A1 (0.36) | ALDH1A1CFTRGOPC | |
| SCHEMBL532970 | 0.71 | ALDH1A1 (0.67) | ALDH1A1PDE4BLMNAKMT2ASLC22A2 | |
| SCHEMBL852224 | 0.71 | ALDH1A1 (0.67) | ALDH1A1PDE4BLMNAKMT2ASLC22A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4700052-A1 | HYBRID SUPPORTED METALLOCENE CATALYST AND METHOD FOR PREPARING POLYETHYLENE USING SAME | LG Chem, Ltd. (KR) | 2026-02-25 | — | — | EP | disclosed |
| US-11685711-B2 | Carbon monoxide-releasing molecules triggered by physiological stimuli | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2023-06-27 | — | — | US | disclosed |
| US-20200283382-A1 | CARBON MONOXIDE-RELEASING MOLECULES TRIGGERED BY PHYSIOLOGICAL STIMULI | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2020-09-10 | — | — | US | disclosed |
| WO-2019032879-A1 | CARBON MONOXIDE-RELEASING MOLECULES TRIGGERED BY PHYSIOLOGICAL STIMULI | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2019-02-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200283382-A1 | CARBON MONOXIDE-RELEASING MOLECULES TRIGGERED BY PHYSIOLOGICAL STIMULI | MB, CA2, HMOX2 | ALDH1A1 3046/4885PDE4B 1444/4885CFTR 1913/4885 |
| US-11685711-B2 | Carbon monoxide-releasing molecules triggered by physiological stimuli | MB, CA2, HMOX2 | ALDH1A1 3046/4885PDE4B 1444/4885CFTR 1913/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.